Health Equity for Medical Devices: FDA Discussion
The Health Equity discussion with the regulated industry has been heavily weighted towards drugs and biologics. However, lack of diversity is an issue for medical device clinical trials as well. The FDA listed several considerations in its discussion paper this week on the topic aiming to collect feedback from the device industry and other stakeholders … Read more
